Prexton Therapeutics
Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life of people who suffer from Parkinson's disease and other brain disorders.
1
Funding Rounds
$41.0m
Money raised
Overview
Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life of people who suffer from Parkinson's disease and other brain disorders.
- Website:
Funding series
Funding Series Analysis
The company Prexton Therapeutics has raised a total of $31m in funding over 1 rounds.
Key Insights:
- Prexton Therapeutics Series B round, February 2017: $31m
Prexton Therapeutics Series B round, February 2017
$31m